老年医学
Age-Related Medicine.
作者信息
Wahlich John, Orlu Mine, Mair Alpana, Stegemann Sven, van Riet-Nales Diana
机构信息
Academy of Pharmaceutical Sciences, 4 Heydon Road, Great Chishill, Royston, Herts SG8 8SR, UK.
Department of Pharmaceutics, School of Pharmacy, University College London, 29-39 Brunswick Square, London WC1N 1AX, UK.
出版信息
Pharmaceutics. 2019 Apr 9;11(4):172. doi: 10.3390/pharmaceutics11040172.
Abstract
A meeting organised by the Academy of Pharmaceutical Sciences focussed on the challenges of developing medicines for older adults. International experts discussed the complexity introduced by polypharmacy and multiple morbidities and how the risk⁻benefit ratio of a medicine changes as an individual ages. The way in which regulatory authorities are encouraging the development of age-appropriate medicines was highlighted. Examples were provided of the difficulties faced by the older population with some medicinal products and suggestions given as to how the pharmaceutical scientist can build the requirements of the older population into their development of new medicines, as well as improvements to existing ones.
摘要
由药物科学研究院组织的一次会议聚焦于为老年人开发药物所面临的挑战。国际专家们讨论了多重用药和多种疾病带来的复杂性，以及药物的风险效益比如何随着个体年龄的增长而变化。会议强调了监管机构鼓励开发适合不同年龄段药物的方式。会上列举了老年人群在使用某些药品时所面临的困难，并就药物科学家如何在新药研发以及现有药物改进过程中将老年人群的需求考虑在内提出了建议。
相似文献
1
Age-Related Medicine.老年医学
Pharmaceutics. 2019 Apr 9;11(4):172. doi: 10.3390/pharmaceutics11040172.
2
Meeting commentary--"medicines for older adults: learning from practice to develop patient centric drug products".会议评论——“老年人用药：从实践中学习，开发以患者为中心的药物产品”。
Int J Pharm. 2013 Nov 1;456(1):251-7. doi: 10.1016/j.ijpharm.2013.07.038. Epub 2013 Aug 3.
3
Evolving regulatory perspectives on digital health technologies for medicinal product development.药品研发中数字健康技术不断演变的监管视角。
NPJ Digit Med. 2023 Mar 29;6(1):56. doi: 10.1038/s41746-023-00790-2.
4
Fighting trafficking of falsified and substandard medicinal products in Russia.打击俄罗斯假药和劣药的非法交易。
Int J Risk Saf Med. 2015;27 Suppl 1:S37-40. doi: 10.3233/JRS-150681.
5
Meeting commentary--"Parkinson's disease: From patient to product".会议评论——“帕金森病：从患者到产品”。
Int J Pharm. 2015 Oct 15;494(1):167-71. doi: 10.1016/j.ijpharm.2015.07.074. Epub 2015 Aug 3.
6
The patterns and implications of potentially suboptimal medicine regimens among older adults: a narrative review.老年人中潜在的次优药物治疗方案的模式及影响：一项叙述性综述
Ther Adv Drug Saf. 2022 Jul 4;13:20420986221100117. doi: 10.1177/20420986221100117. eCollection 2022.
7
Commentary on the EMA reflection paper on the pharmaceutical development of medicines for use in the older population.关于欧洲药品管理局（EMA）关于老年人群用药药品研发反思文件的评论
Br J Clin Pharmacol. 2022 Feb;88(4):1500-1514. doi: 10.1111/bcp.15207. Epub 2022 Feb 9.
8
What makes joint assessment procedures attractive to the innovative industry: successes, challenges, and proposed improvements.联合评估程序对创新产业具有吸引力的因素：成功之处、挑战及改进建议。
Front Med (Lausanne). 2023 Sep 4;10:1207954. doi: 10.3389/fmed.2023.1207954. eCollection 2023.
9
[Early achievements of the Danish pharmaceutical industry--8. Lundbeck].[丹麦制药行业的早期成就——8. 灵北公司]
Theriaca. 2016(43):9-61.
10
Developing patient-centric medicines for older people: Reflections from the draft EMA paper on the pharmaceutical development of medicines for use in the older population.为老年人开发以患者为中心的药物：欧洲药品管理局关于老年人群用药药物研发的文件草案引发的思考
Br J Clin Pharmacol. 2020 Oct;86(10):2008-2013. doi: 10.1111/bcp.14530.
引用本文的文献
1
Prevalence and patient-rated relevance of complexity factors in medication regimens of community-dwelling patients with polypharmacy.社区中同时使用多种药物的患者的药物治疗方案中复杂因素的流行程度和患者评价的相关性。
Eur J Clin Pharmacol. 2022 Jul;78(7):1127-1136. doi: 10.1007/s00228-022-03314-1. Epub 2022 Apr 27.
2
Relationship of Self Efficacy in Medication Understanding with Quality of Life among Elderly with Type 2 Diabetes Mellitus on Polypharmacy in Malaysia.马来西亚多药治疗的 2 型糖尿病老年患者药物理解自我效能与生活质量的关系。
Int J Environ Res Public Health. 2022 Mar 4;19(5):3031. doi: 10.3390/ijerph19053031.
3
Review of Clinical Questions Submitted to Norwegian Drug Information Centres Concerning Administration and Dosage to Older Patients of Relevance to Patient-Centric Care.提交给挪威药物信息中心的关于老年患者给药和剂量的临床问题综述，与以患者为中心的护理相关。
Pharmaceutics. 2021 Jan 14;13(1):105. doi: 10.3390/pharmaceutics13010105.
4
Better Medicines for Older Patients: Considerations between Patient Characteristics and Solid Oral Dosage Form Designs to Improve Swallowing Experience.老年患者的更佳药物：患者特征与固体口服剂型设计之间的考量以改善吞咽体验
Pharmaceutics. 2020 Dec 28;13(1):32. doi: 10.3390/pharmaceutics13010032.
5
Age-Related Changes in the Thermoregulatory Properties in Bank Voles From a Selection Experiment.来自选择实验的棕背䶄体温调节特性的年龄相关变化。
Front Physiol. 2020 Nov 19;11:576304. doi: 10.3389/fphys.2020.576304. eCollection 2020.
本文引用的文献
1
Patient centric drug product design in modern drug delivery as an opportunity to increase safety and effectiveness.以患者为中心的药物产品设计在现代药物传递中的应用机会，旨在提高安全性和有效性。
Expert Opin Drug Deliv. 2018 Jun;15(6):619-627. doi: 10.1080/17425247.2018.1472571. Epub 2018 May 9.
2
Patients with multimorbidity and their treatment burden in different daily life domains: a qualitative study in primary care in the Netherlands and Belgium.患有多种疾病的患者及其在不同日常生活领域的治疗负担：荷兰和比利时初级保健的定性研究
J Comorb. 2018 Mar 8;8(1):9-15. doi: 10.15256/joc.2018.8.119. eCollection 2018.
3
Defining Death-Making Sense of the Case of Jahi McMath.界定死亡——解读贾希·麦克马思事件
JAMA. 2018 May 8;319(18):1859-1860. doi: 10.1001/jama.2018.3441.
4
What is polypharmacy? A systematic review of definitions.什么是多重用药？定义的系统综述。
BMC Geriatr. 2017 Oct 10;17(1):230. doi: 10.1186/s12877-017-0621-2.
5
Patients' appropriateness, acceptability, usability and preferences for pharmaceutical preparations: Results from a literature review on clinical evidence.患者对药物制剂的适宜性、可接受性、可用性和偏好：临床证据文献综述的结果。
Int J Pharm. 2017 Apr 15;521(1-2):294-305. doi: 10.1016/j.ijpharm.2017.02.029. Epub 2017 Feb 14.
6
[Subjective theories on quality of life and health in old age : An explorative study with nursing home residents and their nursing personnel].[关于老年人生活质量与健康的主观理论：一项针对养老院居民及其护理人员的探索性研究]
Z Gerontol Geriatr. 2018 Aug;51(6):628-635. doi: 10.1007/s00391-017-1188-4. Epub 2017 Jan 25.
7
Is Polypharmacy Associated with Frailty in Older People? Results From the ESTHER Cohort Study.多病共存与老年人虚弱有关吗？埃丝特队列研究的结果。
J Am Geriatr Soc. 2017 Feb;65(2):e27-e32. doi: 10.1111/jgs.14718. Epub 2016 Dec 26.
8
Evidence for a limit to human lifespan.人类寿命极限的证据。
Nature. 2016 Oct 13;538(7624):257-259. doi: 10.1038/nature19793. Epub 2016 Oct 5.
9
Baseline Frailty Evaluation in Drug Development.药物研发中的基线虚弱评估。
J Frailty Aging. 2016;5(3):139-40. doi: 10.14283/jfa.2016.99.
10
Biomarkers of Aging: From Function to Molecular Biology.衰老的生物标志物：从功能到分子生物学
Nutrients. 2016 Jun 2;8(6):338. doi: 10.3390/nu8060338.
Zotero 插件